Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) stock after the Company’s stock price dropped significantly during intraday trading today.
INVESTORS OF TRANSMEDICS STOCK WITH FINANCIAL LOSSES MAY HAVE LEGAL OPTIONS AND ARE ENCOURAGED TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE EVALUATION OF POTENTIAL SECURITIES CLAIMS RELATED TO TMDX’S STOCK DROP.
The Company’s stock decline follows the release of a critical report by Scorpion Capital, accusing TransMedics of unethical business practices, including extortion, racketeering, and organ trafficking under the guise of a medical device company.
Key Allegations in the Scorpion Capital Report:
- “Mafia-style” extortion, racketeering, and organ trafficking schemes
- Kickbacks and billing fraud
- Unreported device failures and off-label misuse of the Organ Care System
INVESTORS OF TRANSMEDICS STOCK WITH FINANCIAL LOSSES INTERESTED IN LEARNING MORE ABOUT THE CLASS ACTION INVESTIGATION ALSO CAN CLICK HERE, EMAIL [email protected], OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected].
